January 7, 2021 09:51 AM ESTUpdated 11:27 AM
Outsourcing

Fu­ji­film's CD­MO arm plots mas­sive $2B plant in the US for broad range of ther­a­peu­tics

Conner Mitchell

Buoyed by in­ter­est from ma­jor Covid-19 vac­cine mak­ers for its vi­ral-vec­tor ca­pa­bil­i­ties, Fu­ji­film’s CD­MO arm has looked to rapid­ly build its US foot­print to meet …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

In­tel­lia touts first clin­i­cal out­comes on CRISPR-based AT­TR amy­loi­do­sis as­set

Scot­tish biotech de­buts with ‘Tro­jan horse’ plat­form for can­cer

Ei­sai ter­mi­nates Phase 3 tri­al of Dravet drug, cit­ing re­cruit­ment chal­lenges

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

Ex­clu­sive: Athena Coun­tou­ri­o­tis' Aven­zo taps Shang­hai biotech for ADC, adds new funds

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times